Comparative epidemiology of CTX-M-14 and CTX-M-15 producing Escherichia coli: Association with distinct demographic groups in the community in New Zealand

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 8, 2012, Pages 2057-2060

  Freeman, J T ^a   Williamson, D A ^a   Heffernan, H ^b   Smith, M ^a   Bower, J E ^a   Roberts, S A ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b INSTITUTE OF ENVIRONMENTAL SCIENCE AND RESEARCH   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE CTX M; BETA LACTAMASE CTX M 14; BETA LACTAMASE CTX M 15; BETA LACTAMASE CTX M 27; BETA LACTAMASE CTX M 3; BETA LACTAMASE CTX M 57; BETA LACTAMASE CTX M 65; BETA LACTAMASE CTX M 9; CIPROFLOXACIN; COTRIMOXAZOLE; FOSFOMYCIN; GENTAMICIN; MECILLINAM; NITROFURANTOIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TRIMETHOPRIM; UNCLASSIFIED DRUG;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; ASIAN; CHINESE; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; ESCHERICHIA COLI; ETHNICITY; FEMALE; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALE; NEW ZEALAND; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; TRAVEL;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; COMMUNITY-ACQUIRED INFECTIONS; DEMOGRAPHY; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ETHNIC GROUPS; FEMALE; FLUOROQUINOLONES; HUMANS; MALE; MIDDLE AGED; NEW ZEALAND; RISK FACTORS; YOUNG ADULT;

EID: 84866355216     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1540-3     Document Type: Article

References (15)

1. Cantón R, Coque TM (2006) The CTX-M β-lactamase pandemic. Curr Opin Microbiol 9:466-475
2. Heffernan H, Pope C, Carter P (2007) Identification of extended-spectrum β-lactamase types, plasmid mediated AmpC β-lactamases and strains among urinary Escherichia coli and Klebsiella in New Zealand in 2006. URL: http:// www.surv.esr.cri.nz/PDF-surveillance/Antimicrobial/ESBL/ ESBLIdentification-2006.pdf. Accessed 9 January 2012
3. Rossolini GM, D'Andrea MM, Mugnaioli C (2008) The spread of CTX-M-type extended-spectrum β-lactamases. Clin Microbiol Infect 14:33-41
4. Pitout JD, Gregson DB, Church DL et al (2005) Community-wide outbreaks of clonally related CTX-M-14 β-lactamase-producing Escherichia coli strains in the Calgary health region. J ClinMicrobiol 43:2844-2849 (Pubitemid 40834300)
5. Ben Ami R, Schwaber MJ, Nanon-Venezia S et al (2006) Influx of extended-spectrum β-lactamase-producing Enterobacteriaceae into the hospital. Clin Infect Dis 42:925-934
6. Calbo E, Romani V, Xercavins M et al (2006) Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum β-lactamases. J Antimicrob Chemother 57:780-783
7. Rodríguez-Baño J, Picón E, Gijón P et al (2010) Community-onset bacteremia due to extended-spectrum beta-lactamase- producing Escherichia coli: risk factors and prognosis. Clin Infect Dis 50 (1):40-48
8. Clinical and Laboratory Standards Institute (2010) Performance standards for antimicrobial susceptibility testing; CLSI document M100-S20. Clinical and Laboratory Standards Institute, Wayne, PA
9. Jeong SH, Bae IK, Kwon SB et al (2005) Dissemination of transferable CTX-M-type extended-spectrum β-lactamaseproducing Escherichia coli in Korea. J Appl Microbiol 98:921- 927 (Pubitemid 40477269)
10. De Gheldre Y, Avesani V, Berhin C, Delmee M, Glupczynski Y (2003) Evaluation of Oxoid combination discs for detection of extended-spectrum ß-lactamases. J Antimicrob Chemother 52:591-597 (Pubitemid 37258418)
11. Tenover FC, Arbeit RD, Goering RV et al (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33:2233-2239
12. Ensor V, Shahid M, Evans J, Hawkey P (2006) Occurrence, prevalence and genetic environment of CTX-M β-lactamases in Enterobacteriaceae from Indian hospitals. J Antimicrob Chemother 58:1260-1263 (Pubitemid 44884149)
13. Chen YH, Hsueh PR, Badal RE et al (2011) Antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region according to currently established susceptibility interpretive criteria. J Infect 62(4):280-291
14. Pitout JD, Campbell L, Church DL et al (2009) Molecular characteristics of travel-related extended-spectrum β-lactamase-producing Escherichia coli isolates from the Calgary health region. Antimicrob Agents Chemother 53:2539-2543
15. Manges AR, Tabor H, Tellis P, Vincent C, Tellier PP (2008) Endemic and epidemic lineages of Escherichia coli that cause urinary tract infections. Emerg Infect Dis 14:1575-1583